Press Release| Investors | Medtronic

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2019

DUBLIN - February 8, 2019 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the third quarter of fiscal year 2019 on Tuesday, February 19 , 2019. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2019, which ended on Friday, January 25, 2019.

Medtronic will host a webcast at 7:00 a.m. CST to discuss financial results for its third quarter of fiscal year 2019. The webcast can be accessed at http://investorrelations.medtronic.com on February 19 , 2019.

Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.

Looking ahead, Medtronic plans to report its fiscal year 2019  fourth quarter financial results on Thursday, May 23, 2019. Medtronic plans to report its fiscal year 2020 first and second quarter results on Tuesday, August 20, 2019, and Tuesday, November 19, 2019, respectively. Confirmation and additional details will be provided closer to the specific event.

About Medtronic
  Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:
  Fernando Vivanco
  Public Relations
  +1-763-505-3780
 
  Ryan Weispfenning
  Investor Relations
  +1-763-505-4626

X